ATYR 1923 was developed for the potential treatment of severe pulmonary diseases with an immune and fibrotic component , including interstitial lung disease .
ATYR 1923 is an engineered fusion protein .
fusion protein   was developed for the potential treatment of severe pulmonary diseases with an immune and fibrotic component , including interstitial lung disease .
ATYR 1923 is an engineered fusion protein .